Advanced Search

Fungal Infection Stocks List

Symbol Grade Name % Change
GILD D Gilead Sciences, Inc. -0.69
SCYX D SCYNEXIS, Inc. -2.61
NOVN D Novan, Inc. -6.76
TLC C Taiwan Liposome Company, Ltd. -1.80
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
Related Stock Lists: Fungal Infections Biopharmaceutical Drugs Inflammation Medicine Acne Acne Vulgaris Amphotericin B Angina Antibiotic Anti Infectives Arbutus Biopharma Arthritis Bupivacaine Cardiovascular Disease Cardiovascular Diseases Chemical Entities Coronavirus Corticosteroid Cutaneous Conditions

Related ETFs - A few ETFs which own one or more of the above listed Fungal Infection stocks.

Symbol Grade Name Weight
DWSH F AdvisorShares Dorsey Wright Short ETF 24.73
BIS C ProShares UltraShort Nasdaq Biotechnology 7.41
IBB D iShares Nasdaq Biotechnology Index Fund 6.93
PJP D PowerShares Dynamic Pharmaceuticals 5.47
HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 5.35
View all Fungal Infection related ETFs...
Compare ETFs
  • Compare DWSH to BIS
  • Compare DWSH to HDLB
  • Compare IBB to PJP

    • Recent Signals

    Date Stock Signal Type
    2021-04-12 GILD Fell Below 20 DMA Bearish
    2021-04-12 GILD Fell Below 50 DMA Bearish
    2021-04-12 GILD Fell Below 200 DMA Bearish
    2021-04-12 GILD MACD Bearish Signal Line Cross Bearish
    2021-04-12 SCYX Fell Below 20 DMA Bearish
    2021-04-12 SCYX Fell Below 50 DMA Bearish
    2021-04-12 TLC 20 DMA Support Bullish

    Recent News for Fungal Infection Stocks

    Date Stock Title
    Apr 12 SCYX SCYNEXIS (NASDAQ:SCYX) Has Debt But No Earnings; Should You Worry?
    Apr 9 GILD Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor
    Apr 8 GILD Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
    Apr 8 GILD Study shows wearables could detect COVID-19 earlier
    Apr 8 GILD COVID-19 vaccinations are ‘extraordinarily safe’: Doctor
    Apr 8 GILD Gilead (GILD) Gets Full Approval for Breast Cancer Drug Trodelvy
    Apr 8 GILD The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
    Apr 8 GILD Gilead wins full FDA approval for Trodelvy in triple-negative breast cancer
    Apr 8 GILD Gilead's Trodelvy Wins FDA Regular Approval For Triple-Negative Breast Cancer
    Apr 7 GILD FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival
    Apr 7 GILD Biotech Stock Roundup: ACAD Down on CRL, EBS Gets Additional Order & Other Updates
    Apr 6 GILD There’s increasing confidence vaccine supply can meet demand: Doctor
    Apr 6 GILD Exclusive: Precigen's CEO Breaks Down Biotech's Oncology Platforms, Technology, Differentiators
    Apr 6 GILD Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly
    Apr 6 GILD NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Fungal Infections Biopharmaceutical Drugs Inflammation Medicine Acne Acne Vulgaris Amphotericin B Angina Antibiotic Anti Infectives Arbutus Biopharma Arthritis Bupivacaine Cardiovascular Disease Cardiovascular Diseases Chemical Entities Coronavirus Corticosteroid Cutaneous Conditions

    Browse All Tags